Drug Profile
Research programme: drug discovery - (now Teva Pharmaceutical Industries)/Pharmacopeia
Latest Information Update: 09 Oct 2009
Price :
$50
*
At a glance
- Originator Cephalon; Pharmacopeia Drug Discovery
- Developer Cephalon; Pharmacopeia
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 09 Oct 2009 Preclinical development is ongoing in USA
- 30 Sep 2009 Discontinued - Preclinical for Undefined indication in USA (unspecified route)
- 23 Dec 2008 Pharmacopeia has been acquired by Ligand Pharmaceuticals